Monitoring of the Safety and the Performance of the Endoscopic Cap Electrode (ECE50)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

384 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-12-16

Study Completion Date

2031-12-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this registry is to confirm the safety and the performance of the ECE50 in medical routine by collecting data.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluating the Use of a Device Called Impulse Oscillometry in Participants With Vocal Cord Disorders or Asthma

NCT05246930

Breathing, Mouth Lung Function Decreased Vocal Cord Dysfunction +2 more

COMPLETED

Incidence of Dysphagia in Intensive Care Patients With Tracheostomy

NCT02874352

Dysphagia Oropharyngeal Dysphagia

UNKNOWN NA

Retromolar Route Access With and Without A Retromolar Gap

NCT02611141

Airway Management

COMPLETED NA

A Comparison of the Blom Low Profile Voice Inner Cannula and the Passy-Muir One-Way Tracheotomy Tube Speaking Valve on Voice Production, Speech Intelligibility, and Biomechanical Swallowing Behavior

NCT01784224

Mechanical Complication of Tracheostomy

COMPLETED NA

Comparison of Different Video Laryngoscopes in a Manikin With Immobilized Cervical Spine

NCT01210092

Tracheal Intubation

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Endoscopic Cap Electrode (ECE50) has been designed for the delivery of electrostimulation to selected laryngeal muscles. The primary objective of this registry is to retrieve real-life data on the safety and performance of the Endoscopic Cap in medical routine. Subject's participation will last a maximum of 2 hours. Upon successful conclusion of the screening session starts the testing session of the ECE50. The ECE50 has been designed to be placed on the top of a videoendoscope for the delivery of electrostimulation to the laryngeal region. The stimulation and reaction of the muscles can provide information about the presence and type of dysfunctions and thus influence the treatment procedure. Being a registry a collection of records generated within routine medical procedures with a medical device approved for the EU market, it does not pose additional risks for the patients participating in it.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vocal Fold Paresis Laryngeal Dystonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Legal adults (i.e., as a general rule patients ≥ 18 years old)
* Legal adults requiring a diagnosis for a disorder that could be traced back to uni- or bilateral dysfunction of one or more laryngeal muscle(s) of the posterior cricoid region
* Signed and dated informed consent before the start of any registry-specific procedure for all the recruited subjects

* Use of an active medical implant
* Known allergies or intolerance to the material used for this registry
* Parallel participation in a device/drug registry in the period of data collection, which could confound the results of the registry
* Anything that, in the opinion of the Registry Responsible, would place the subject at increased risk or preclude the subject's full compliance with the general requirements of this registry

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No